Overview

C-Reactive Protein Test (CRP) Market is forecasted to value over USD xx billion by 2027 end and register a CAGR of 2.7% from the forecast period 2020-2027.

FutureWise Market Research has instantiated a report that report provides an intricate analysis of the Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market.
According to the research study conducted by FutureWise research analysts, the Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the C-Reactive Protein Test (CRP) Market long with the growth opportunities present across this business vertical.
Major players included in the Market are:    

• BECKMAN COULTER    
• ROCHE  
• SIEMENS HEALTHCARE    
• ORTHO CLINICAL DIAGNOSTICS  
• BODITECH
• FUJIFILM
• KANTO CHEMICAL
• KEHUA GROUP
• WONFO
• RANDOX LABORATORIES LTD
• GETEIN BIOTECH, INC.

(Note: The list of the major players will be updated with the latest market scenario and trends)

C-Reactive Protein Test (CRP) Market Segmentation:

By Assay Type

• ELISA
• Clinical
• Nonclinical
• Immunoturbidimetric
• CLIA
• Others

By Detection Range

• hs-CRP
• Conventional CRP
• cCRP

By Disease Area

• Cardiovascular Diseases
• Cancer
• Rheumatoid Arthritis
• Inflammatory Bowel Disease
• Endometriosis
• Lupus
• Others

By End User

• Hospitals
• Diagnostic Laboratories
• Clinics
• Laboratories
• Home
• Others

By Region
• North America
• Europe
• Asia-Pacific
• Rest of the world
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the Market by type, by application and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
        1.1. Objectives of the Study 
        1.2. Market Definition 
        1.3. Market Scope 
               1.3.1. Years Considered for the Study
               1.3.2. Market Covered
        1.4. Currency 
        1.5. Limitations 
        1.6. Stakeholders 
 2.  Research Methodology 
        2.1. Research Data 
               2.1.1. Secondary Data
                          2.1.1.1. Key Data from Secondary Sources
               2.1.2. Primary Data
         2.1.2.1. Key Data from Primary Sources
        2.2. Market Size Estimation 
        2.3. Market Breakdown and Data Triangulation 
        2.4. Assumptions for the Study  
3. Executive Summary
        3.1. Market Outlook
        3.2. Segment Outlook
        3.3. Competitive Insights
4. Global C-Reactive Protein Test (CRP) Market Variables, Trends & Scope
        4.1. Market Lineage Outlook
        4.2. Penetration and Growth Prospect Mapping
        4.3. Industry Value Chain Analysis
        4.4. Cost Analysis Breakdown
        4.5. Technology Overview
        4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Global C-Reactive Protein Test (CRP) Market Overview
        5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of C-Reactive Protein Test (CRP) Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global C-Reactive Protein Test (CRP) Market Analysis Tools
        6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
        6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
        6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
        6.4. Market Entry Strategies
        6.5. Case Studies
7. Global C-Reactive Protein Test (CRP) Market, By Assay Type Historical Analysis and Forecast 2020-2027 (USD Million)
        7.1. ELISA
              7.1.1. Clinical
              7.1.2. Nonclinical
        7.2. Immunoturbidimetric
        7.3. CLIA
        7.4. Others
8. Global C-Reactive Protein Test (CRP) Market, By Detection Range Historical Analysis and Forecast 2020-2027 (USD Million)
        8.1. hs-CRP
        8.2. Conventional CRP
        8.3. cCRP 
9. Global C-Reactive Protein Test (CRP) Market, By Disease Area Historical Analysis and Forecast 2020-2027 (USD Million)
        9.1. Cardiovascular Diseases
        9.2. Cancer
        9.3. Rheumatoid Arthritis 
        9.4. Inflammatory Bowel Disease
       9.5. Endometriosis
       9.6. Lupus
       9.7. Others
10. Global C-Reactive Protein Test (CRP) Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
        10.1. Hospitals
        10.2. Diagnostic Laboratories
        10.3. Clinics
        10.4. Laboratories
        10.5. Home
        10.6. Others
11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        11.1. Introduction
        11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  11.2.1. U.S.A
                  11.2.2. Canada
                  11.2.3. Mexico
        11.3. Market Size (USD Million) Forecast for North America 2020-2027 
12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        12.1. Introduction
        12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                 12.2.1. Brazil
                 12.2.2. Venezuela
                 12.2.3. Argentina
                 12.2.4. Rest of Latin America
        12.3. Market Size (USD Million) Forecast for Latin America 2020-2027  
13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        13.1. Introduction
        13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  13.2.1. Germany
                  13.2.2. U.K
                  13.2.3. France
                  13.2.4. Italy
                  13.2.5. Spain
                  13.2.6. Russia
                  13.2.7. Poland
                  13.2.8. Rest of Europe
        13.3. Market Size (USD Million) Forecast for Europe 2020-2027
14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        14.1. Introduction
        14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  14.2.1. Japan
                  14.2.2. China
                  14.2.3. India
                  14.2.4. Australia and New Zealand
                  14.2.5. ASEAN
                  14.2.6. Rest of Asia Pacific
        14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        15.1. Introduction
        15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                  15.2.1. Saudi Arabia
                  15.2.2. UAE
                  15.2.3. South Africa
                  15.2.4. Egypt
        15.3. Market Size (USD Million) Forecast for MEA 2020-2027           
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
        16.1. BECKMAN COULTER    
                   16.1.1. Company Overview
                   16.1.2. Product Portfolio
                   16.1.3. SWOT Analysis
                   16.1.4. Financial Overview
                   16.1.5. Strategic Overview
        16.2. ROCHE  .
                   16.2.1. Company Overview
                   16.2.2. Product Portfolio
                   16.2.3. SWOT Analysis
                   16.2.4. Financial Overview
                   16.2.5. Strategic Overview
        16.3. SIEMENS HEALTHCARE
                   16.3.1. Company Overview
                   16.3.2. Product Portfolio
                   16.3.3. SWOT Analysis
                   16.3.4. Financial Overview
                   16.3.5. Strategic Overview
        16.4. ORTHO CLINICAL DIAGNOSTICS  
                   16.4.1. Company Overview
                   16.4.2. Product Portfolio
                   16.4.3. SWOT Analysis
                   16.4.4. Financial Overview
                   16.4.5. Strategic Overview
        16.5 BODITECH
                   16.5.1. Company Overview
                   16.5.2. Product Portfolio
                   16.5.3. SWOT Analysis
                   16.5.4. Financial Overview
                   16.5.5. Strategic Overview
        16.6 FUJIFILM
                   16.6.1. Company Overview
                   16.6.2. Product Portfolio
                   16.6.3. SWOT Analysis
                   16.6.4. Financial Overview
                   16.6.5. Strategic Overview
        16.7. KANTO CHEMICAL
                   16.7.1. Company Overview
                   16.7.2. Product Portfolio
                   16.7.3. SWOT Analysis
                   16.7.4. Financial Overview
                   16.7.5. Strategic Overview
        16.8. KEHUA GROUP
                   16.8.1. Company Overview
                   16.8.2. Product Portfolio
                   16.8.3. SWOT Analysis
                   16.8.4. Financial Overview
                   16.8.5. Strategic Overview
        16.9. WONDFO
                   16.9.1. Company Overview
                   16.9.2. Product Portfolio
                   16.9.3. SWOT Analysis
                   16.9.4. Financial Overview
                   16.9.5. Strategic Overview
        16.10. RANDOX LABORATORIES LTD
                   16.10.1. Company Overview
                   16.10.2. Product Portfolio
                   16.10.3. SWOT Analysis
                   16.10.4. Financial Overview
                   16.10.5. Strategic Overview
        16.11. GETEInN BIOTECH, INC.
                   16.11.1. Company Overview
                   16.11.2. Product Portfolio
                   16.11.3. SWOT Analysis
                   16.11.4. Financial Overview
                   16.11.5. Strategic Overview
   17. FutureWise SME Key Takeaway Points for Client

Tables

Figures